Abstract:Background: Inclusion bodies (IBs) are protein aggregates in recombinant bacterial cells containing mainly the target recombinant protein. Although it has been shown that IBs contain functional proteins along with protein aggregates, their direct application as pharmaceuticals is hindered by their heterogeneity and hazardous contaminants with bacterial origin. Therefore, together with the production of soluble species, IBs remain the main source for manufacture of recombinant proteins with medical application. The quality and composition of the IBs affect the refolding yield and further purification of the recombinant protein. The knowledge whether nucleic acids are genuine components or concomitant impurities of the IBs is a prerequisite for the understanding of the IBs formation and for development of optimized protocols for recombinant protein refolding and purification. IBs isolated from Escherichia coli overexpressing human interferon-gamma (hIFNγ), a protein with therapeutic application, were used as a model. Results: IBs were isolated from E. coli LE392 cells transformed with a hIFNγ expressing plasmid under standard conditions and further purified by centrifugation on a sucrose cushion, followed by several steps of sonication and washings with non-denaturing concentrations of urea. The efficiency of the purification was estimated by SDS-PAGE gel electrophoresis and parallel microbiological testing for the presence of residual intact bacteria. Phenol/chloroform extraction showed that the highly purified IBs contain both DNA and RNA. The latter were studied by UV spectroscopy and agarose gel electrophoresis combined with enzymatic treatment and hybridization. DNA was observed as a diffuse fraction mainly in the range of 250 to 1000 bp. RNA isolated by TRIzol® also demonstrated a substantial molecular heterogeneity. Hybridization with 32P-labelled oligonucleotides showed that the IBs contain rRNA and are enriched of hIFNγ mRNA. Conclusions: The results presented in this study indicate that the nucleic acids might be intrinsic components rather than co-precipitated impurities in the IBs. We assume that the nucleic acids are active participants in the aggregation of recombinant proteins and formation of the IBs that originate from the transcription and translation machinery of the microbial cell factory. Further studies are needed to ascertain this notion.

Purification and characterization of recombinant human interferon-γ from Chinese Han nationality

Refolding of recombinant human interferon-gamma by expanded bed adsorption chromatography with urea gradient

Cloning, Prokaryotic Expression and the Construction of Eukaryotic Vector of the Gene Encoding Mature Interferon-Gamma Protein from Xiao-shan Chicken

Optimization of soluble human interferon-γ production in Escherichia coli using SUMO fusion partner

Study on the Cloning and Expression of Human Fibrinogen α ,β, γ Gene

Purification and Characterization of Non-Fusion Recombinant Human Interleukin-18 Expressed in E. Coli

Transfection and Expression of the Recombinant Adeno-Associated Virus Carrying Human Interferon-Γ in Human Lymphocyte

A Novel Gene of Chain of the IFN- Receptor of Huiyang Chicken: Cloning, Distribution, and CD Assay

Efficient expression and purification of human interferon alpha2b in the methylotrophic yeast, Pichia pastoris

Refolding of Recombinant Human Interferon Gamma Inclusion Bodies in Vitro Assisted by Colloidal Thermo-Sensitive Poly(n-Isopropylacrylamide) Brushes Grafted Onto the Surface of Uniform Polystyrene Cores

Expression of recombinant plasmid of HIV-1 gp120 and IFN-gamma in E. coli and its immunoregulatory effect]

Expression, Purification and Characterization of a Functional Extracellular Domain of Porcine FcgammaRII.

Expression and purification of chicken beta interferon and its antivirus immunological activity.

Expression and Identification of Immunological Activities of the HIV‐gp120N‐Human Interferon Gamma Fusion Protein

[Purification of Fusion Protein HSA/IL1ra and Its Bioactivity].

Optimization of conditions for high-level expression and purification of human recombinant consensus interferon (rh-cIFN) and its characterization

Optimization of human interferon beta protein expression in Chinese hamster ovary cells

Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma

A Simplified Process for Purification and Refolding of Recombinant Human Interferon-α2b

Bacterial Expression of the HINab Domain of IFI16: Purification, Characterization of DNA Binding Activity, and Co-Crystallization with Viral Dsdna

[Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body]